Imunon, Inc. (IMNN): Free Cash Flow
-$14.18M
Year ended 2025-12-31
-$15.18M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$14.18M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$18.88M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$19.47M | n/m | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | -$23.36M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$16.54M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$15.64M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$20.61M | n/m | 2021-03-19, From 2019-01-01 |
| 2018-12-31 | -$7.18M | n/m | 2020-03-25, From 2018-01-01 |
| 2017-12-31 | -$16.68M | n/m | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | -$18.44M | n/m | 2018-03-27, From 2016-01-01 |
| 2015-12-31 | -$20.94M | n/m | 2017-03-24, From 2015-01-01 |
| 2014-12-31 | -$22.03M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$9.58M | n/m | 2016-03-30, From 2013-01-01 |
| 2012-12-31 | -$22.76M | n/m | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | -$23.32M | n/m | 2014-03-13, From 2011-01-01 |
| 2010-12-31 | -$13.37M | n/a | 2013-03-18, From 2010-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Imunon, Inc. (IMNN) | 2025-12-31 | -$14.18M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$3.96M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | -$6.38M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2024-12-31 | -$10.64M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2024-12-31 | -$18.34M | n/a |
| NewcelX Ltd. (NCEL) | 2025-12-31 | -$2.77M | n/m |
| MetaVia Inc. (MTVA) | 2025-12-31 | -$15.70M | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$21.21M | n/m |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | -$5.40M | n/m |
Compare IMNN, PRFX, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗